Boston, MA · Founded 2021 · Privately Held (backing)
Developer of a therapeutic discovery platform designed to identify compounds for treating brain and mental health conditions. Sensorium Therapeutics is based in Boston, MA and was founded in 2021. Its last reported valuation was $47 million in Sep 2022. It has raised $69.7 million across 3 recorded rounds; the latest was a $26.8 million early-stage round in Jan 2025.
Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$69.7M
Last round
Early Stage VC
Jan 2025
Cap table — not yet on record
Sensorium Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sensorium Therapeutics with a free account
·The complete investor list: 16 names
·Watch Sensorium Therapeutics: the Monday email on marks, rounds and moves
Where does Sensorium Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Sensorium Therapeutics's 3 recorded funding rounds.
